Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
Author:
Funder
Australian Research Council
Wellcome Trust
Publisher
Elsevier BV
Subject
General Biochemistry, Genetics and Molecular Biology
Reference100 articles.
1. Adaptive platform trials: definition, design, conduct and reporting considerations;Angus;Nat. Rev. Drug Discov.,2019
2. Search-and-replace genome editing without double-strand breaks or donor DNA;Anzalone;Nature,2019
3. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation;Arpaia;Nature,2013
4. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota;Atarashi;Nature,2013
5. Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis;Bachelez;N. Engl. J. Med.,2019
Cited by 205 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The molecular subtypes of autoimmune diseases;Computational and Structural Biotechnology Journal;2024-12
2. STATs, promising targets for the treatment of autoimmune and inflammatory diseases;European Journal of Medicinal Chemistry;2024-11
3. Mesenchymal stromal cells restrain the Th17 cell response via L-amino-acid oxidase within lymph nodes;Cell Death & Disease;2024-09-02
4. Drug delivery technologies for autoimmunity therapies;Advanced Drug Delivery Reviews;2024-09
5. Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis;Cell;2024-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3